<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">Cerebral vasospasm</z:e> is a significant problem after <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo>, with often devastating consequences </plain></SENT>
<SENT sid="1" pm="."><plain>Its pathogenesis remains poorly understood despite extensive research </plain></SENT>
<SENT sid="2" pm="."><plain>Owing to the lack of a clear etiology, medical treatment is still largely limited to triple-H therapy and <z:chebi fb="0" ids="38215">calcium channel blockers</z:chebi>, although newer treatments such as percutaneous transluminal angioplasty and papaverine infusion are becoming more common </plain></SENT>
<SENT sid="3" pm="."><plain>Clinical symptoms are often first noted by the registered nurse, who must then alert the physician to the need for diagnostic workup and therapy </plain></SENT>
<SENT sid="4" pm="."><plain>Caring for patients after <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> requires awareness of the potential for the development of vasospasm, and knowledge of the steps necessary to ensure its timely diagnosis and treatment </plain></SENT>
<SENT sid="5" pm="."><plain>This article will review the current body of knowledge as it pertains to vasospasm and outline the direction of ongoing research </plain></SENT>
</text></document>